Nea Management Company, LLC Trevi Therapeutics, Inc. Transaction History
Nea Management Company, LLC
- $1.05 Billion
- Q1 2025
A detailed history of Nea Management Company, LLC transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 11,370,376 shares of TRVI stock, worth $79.6 Million. This represents 6.78% of its overall portfolio holdings.
Number of Shares
11,370,376
Previous 11,370,376
-0.0%
Holding current value
$79.6 Million
Previous $48.4 Million
47.65%
% of portfolio
6.78%
Previous 3.46%
Shares
6 transactions
Others Institutions Holding TRVI
# of Institutions
144Shares Held
85.3MCall Options Held
1.51MPut Options Held
304K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$71.8 Million4.06% of portfolio
-
Rubric Capital Management LP New York, NY4.54MShares$31.8 Million0.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.84MShares$26.9 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.49MShares$24.4 Million5.95% of portfolio
-
Bio Impact Capital LLC Cambridge, MA3.43MShares$24 Million3.99% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $408M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...